UNLABELLED: Variability is a phenomenon attributed to most biological processes and is a particular feature of blood pressure (BP) that concerns many physicians regarding the clinical meaning and the impact on their clinical practice. In this review, we assessed the role of different indices of BP variability in cardiovascular risk stratification. We reviewed the indices of BP variability derived from ambulatory BP monitoring (day-to-night ratio, morning surge of BP, and short-term BP variability) and home BP measurement (standardized conventional BP measurement and self-BP measurement), and summarized our recent results with the intention to provide a clear message for clinical practice. CONCLUSION: BP variability, either derived from ambulatory BP measurement or home BP measurement does not substantially refine cardiovascular risk prediction over and beyond the BP level. Practitioners should be aware that BP level remains the main modifiable risk factor derived from BP measurement and contributes to improving the control of hypertension and adverse health outcomes.
UNLABELLED: Variability is a phenomenon attributed to most biological processes and is a particular feature of blood pressure (BP) that concerns many physicians regarding the clinical meaning and the impact on their clinical practice. In this review, we assessed the role of different indices of BP variability in cardiovascular risk stratification. We reviewed the indices of BP variability derived from ambulatory BP monitoring (day-to-night ratio, morning surge of BP, and short-term BP variability) and home BP measurement (standardized conventional BP measurement and self-BP measurement), and summarized our recent results with the intention to provide a clear message for clinical practice. CONCLUSION: BP variability, either derived from ambulatory BP measurement or home BP measurement does not substantially refine cardiovascular risk prediction over and beyond the BP level. Practitioners should be aware that BP level remains the main modifiable risk factor derived from BP measurement and contributes to improving the control of hypertension and adverse health outcomes.
Authors: Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Marta Garofoli; Elisa Ramundo; Giorgio Gentile; Giuseppe Ambrosio; Gianpaolo Reboldi Journal: Hypertension Date: 2012-05-14 Impact factor: 10.190
Authors: José Boggia; Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen Journal: Lancet Date: 2007-10-06 Impact factor: 79.321
Authors: Joseph C Watso; Austin T Robinson; Matthew C Babcock; Kamila U Migdal; Megan M Wenner; Sean D Stocker; William B Farquhar Journal: Am J Physiol Regul Integr Comp Physiol Date: 2019-10-16 Impact factor: 3.619
Authors: Kimberly C Blom; Sasha Farina; Yessica-Haydee Gomez; Norm R C Campbell; Brenda R Hemmelgarn; Lyne Cloutier; Donald W McKay; Martin Dawes; Sheldon W Tobe; Peter Bolli; Mark Gelfer; Donna McLean; Gillian Bartlett; Lawrence Joseph; Robin Featherstone; Ernesto L Schiffrin; Stella S Daskalopoulou Journal: Curr Hypertens Rep Date: 2015-04 Impact factor: 5.369
Authors: Anne S M Costa; Paulo H M Costa; Carlos E B de Lima; Luiz E M Pádua; Luciana A Campos; Ovidiu C Baltatu Journal: Front Neurosci Date: 2016-01-11 Impact factor: 4.677
Authors: Bailey DeBarmore; Feng-Chang Lin; Laura A Tuttle; Emily Olsson; Alan Hinderliter; Jeffrey L Klein; Anthony J Viera Journal: J Clin Hypertens (Greenwich) Date: 2018-01-25 Impact factor: 3.738